Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    9552031 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Capecitabine;   Drug: Adjuvant chemotherapy using PF (5-Fluorouracil );   Drug: Induction chemotherapy using PF (5-Fluorouracil)
2 Recruiting A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Docetaxel (DOC);   Drug: Cisplatin (DDP);   Radiation: Concurrent chemoradiation (CRT)
3 Terminated Photon/Proton Radiation Therapy for Carcinoma of the Nasopharynx
Condition: Nasopharynx Cancer
Intervention:

Study has passed its completion date and status has not been verified in more than two years.